Pilsicainide-induced polymorphic ventricular tachycardia. 2012

Yoshiaki Kaneko, and Tadashi Nakajima, and Toshimitsu Kato, and Masahiko Kurabayashi
Department of Medicine and Biological Medicine, Gunma University Graduate School of Medicine, Japan. kanekoy@gunma-u.ac.jp

UI MeSH Term Description Entries
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D017180 Tachycardia, Ventricular An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation). Idiopathic Ventricular Tachycardia,Nonsustained Ventricular Tachycardia,Paroxysmal Supraventricular Tachycardia,Ventricular Tachyarrhythmias,Ventricular Tachycardia,Idiopathic Ventricular Tachycardias,Nonsustained Ventricular Tachycardias,Paroxysmal Supraventricular Tachycardias,Supraventricular Tachycardia, Paroxysmal,Tachyarrhythmia, Ventricular,Tachycardia, Idiopathic Ventricular,Tachycardia, Nonsustained Ventricular,Tachycardia, Paroxysmal Supraventricular,Ventricular Tachyarrhythmia,Ventricular Tachycardia, Idiopathic,Ventricular Tachycardia, Nonsustained,Ventricular Tachycardias

Related Publications

Yoshiaki Kaneko, and Tadashi Nakajima, and Toshimitsu Kato, and Masahiko Kurabayashi
May 2006, Pacing and clinical electrophysiology : PACE,
Yoshiaki Kaneko, and Tadashi Nakajima, and Toshimitsu Kato, and Masahiko Kurabayashi
May 2007, Journal of cardiovascular electrophysiology,
Yoshiaki Kaneko, and Tadashi Nakajima, and Toshimitsu Kato, and Masahiko Kurabayashi
September 2006, Pacing and clinical electrophysiology : PACE,
Yoshiaki Kaneko, and Tadashi Nakajima, and Toshimitsu Kato, and Masahiko Kurabayashi
December 2008, The Canadian journal of cardiology,
Yoshiaki Kaneko, and Tadashi Nakajima, and Toshimitsu Kato, and Masahiko Kurabayashi
January 2010, Texas Heart Institute journal,
Yoshiaki Kaneko, and Tadashi Nakajima, and Toshimitsu Kato, and Masahiko Kurabayashi
February 2009, Journal of hospital medicine,
Yoshiaki Kaneko, and Tadashi Nakajima, and Toshimitsu Kato, and Masahiko Kurabayashi
January 1989, Annals of emergency medicine,
Yoshiaki Kaneko, and Tadashi Nakajima, and Toshimitsu Kato, and Masahiko Kurabayashi
January 1996, Ryoikibetsu shokogun shirizu,
Yoshiaki Kaneko, and Tadashi Nakajima, and Toshimitsu Kato, and Masahiko Kurabayashi
February 1994, European heart journal,
Yoshiaki Kaneko, and Tadashi Nakajima, and Toshimitsu Kato, and Masahiko Kurabayashi
September 2002, Pacing and clinical electrophysiology : PACE,
Copied contents to your clipboard!